Skip to main content

Table 2 Demographic data, tumor location, patients’ comorbidities – EC (Elettrocautery); HS (Harmonic Scalpel); SM (LigaSure); TB (ThunderBeat); UEQ (Upper-External Quarter); UIQ (Upper-Internal Quarter); LEQ (Lower-External Quarter); LIQ (Lower-Internal Quarter)

From: Advanced hemostasis in axillary lymph node dissection for locally advanced breast cancer: new technology devices compared in the prevention of seroma formation

 

EC

HS

LS

TB

Patients, n.

25

25

25

25

Age – median [range], yrs

52 [33–70]

49 [35–73]

45 [27–61]

54 [37–68]

Laterality – right breast, n. (%)

15 (61%)

18 (72%)

11 (44%)

14 (56%)

Tumor location – UEQ, n. (%)

13 (52%)

14 (56%)

15 (60%)

11 (44%)

Tumor location – UIQ, n. (%)

6 (24%)

5 (20%)

6 (24%)

7 (28%)

Tumor location – LEQ, n. (%)

4 (16%)

4 (16%)

4 (16%)

3 (12%)

Tumor location – LIQ, n. (%)

2 (8%)

2 (8%)

0 (0%)

4 (16%)

Body mass index - median [range], Kg/m2

27,1 [19–35]

26 [20,5–34]

24,5 [18,6-30,2]

26,8 [22–31,5]

Comorbidities – hypertension, n. (%)

5 (20%)

6 (24%)

4 (16%)

5 (20%)

Comorbidities – Diabetes, n. (%)

1 (4%)

1 (4%)

1 (4%)

0 (0%)